Thoracic manifestations of leukaemia can be divided into those related to the disease itself and those associated with its treatment. Leukaemias are haematologic malignancies in which occur a proliferation of haematopoietic cells at an undifferentiated or partially differentiated stage of maturation.
Thoracic manifestations directly attributed to leukaemia
-
the most frequent manifestation of leukaemia in the thorax
commonly seen in lymphoid leukaemias
axillary lymphadenopathy is more common in CLL (~48%) 6
-
pulmonary leukaemic infiltrates
extravascular collections of leukaemic cells in the lung parenchyma
found in about a quarter of patients in autopsy studies 6
overall similar distribution among the four major types of leukaemia 6
-
over-accumulation of leukaemic cells within the small vessels leading to obstruction 6
it is a medical emergency that presents clinically with acute respiratory failure
-
seen in up to a fifth of cases in autopsies series 6
commonly seen in advanced stages of chronic leukaemias
on imaging, presents as pleural effusion and or soft tissue pleural thickening
-
heart involvement
present in about 25% of cases in autopsies series 6
usually asymptomatic
can potentially involve the pericardium, the myocardium, and the endocardium
-
although the thorax is uncommonly involved, it may occur in the lungs, pleura, mediastinum, chest wall, and breast 6
the mediastinum is the most common site of myeloid sarcoma in the chest 6
-
thoracic cage
for bone, muscular, and soft tissue involvement, please refer to the article on musculoskeletal manifestations of leukaemia
-
associations: some conditions affecting the chest, although without having a clear mechanism of connection, have been reported to occur in patients with leukaemia
-
pulmonary alveolar proteinosis (PAP)
seen in the myeloid forms of leukaemia, particularly CML
-
Leukaemia treatment-related thoracic complications
superimposed infection
leukaemic cell lysis pneumopathy
-
chemotherapy toxicity
-
leukaemic cell lysis pneumopathy
acute respiratory failure after the initiation of chemotherapy, particularly in patients with hyperleukocytosis
features of acute respiratory distress syndrome (ARDS)
See also
-
systemic involvement of leukaemia